Positive lymph nodes do not metastasize
Authors:
- 24 December 2011
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 31 (1-2) , 235-246
Abstract
Our understanding of the role of lymph nodes (LN) in the metastasization process (MET) is marginal. Positive LNs (pLN) are the most important prognostic factor and lymph node dissection (LND) is still standard practice in primary treatment. However, up to now, there is almost no evidence that elective LND has a survival benefit. Based on many clinical and experimental findings, we propose that tumor foci in regional LN are incapable of metastasization and can therefore not infiltrate further LN and organs. Available data demonstrate a very early infiltration of MET capable tumor cells from the primary tumor into regional LN, and thereafter an increased probability of subsequent LN infiltrations. Disparate growth rates of the first versus subsequent infiltrating tumors as well as the asymptotic growth and prognosis of large tumor foci in LN explain many clinical observations for solid tumors. The consequence of the hypothesis “pLN do not metastasize” would impact clinical treatment and research and contribute to understanding the mounting evidence against LND.Keywords
This publication has 78 references indexed in Scilit:
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2011
- Sentinel Lymph Node Biopsy in Breast CancerAnnals of Surgery, 2010
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2009
- Regional Lymph Node Metastases; a Singular Manifestation of the Process of Clinical Metastases in Cancer: Contemporary Animal Research and Clinical Reports Suggest Unifying ConceptsAnnals of Surgical Oncology, 2007
- Sentinel-Node Biopsy or Nodal Observation in MelanomaNew England Journal of Medicine, 2006
- Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical TrialJNCI: Journal of the National Cancer Institute, 2005
- Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group TrialJournal of Clinical Oncology, 2004
- Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by IrradiationNew England Journal of Medicine, 2002
- The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trialEuropean Journal of Cancer, 1999
- Curative resection for left colonic carcinoma: Hemicolectomy vs. Segmental colectomyDiseases of the Colon & Rectum, 1994